Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134667) titled 'Multicenter, randomized, controlled prospective clinical study comparing sandwich chemoradiotherapy with sequential chemoradiotherapy for newly diagnosed stage II-III extranodal NK/T-cell lymphoma' on Oct. 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Hospital of Sichuan University
Condition:
newly diagnosed patients with stage II-III extranodal NK/T-cell lymphoma
Intervention:
Test group:sandwich chemoradiotherapy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-19
Target Sample Size: Test group:246;Control group (Group B):246;...